By John Vibes A set of clinical trials for MDMA, sponsored by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) has now reached “Phase 3,” which brings the substance just a few steps away from getting approved by the US Food and Drug Administration (FDA)….
By John Vibes Over the last ten years, there has been a new surge of scientific research into psychedelics. Scientists are now finally getting a chance to gather information about how psychedelics affect our bodies and minds after many decades of finding themselves limited and…
By Heather Callaghan, Editor Research in recent years has shown that psychedelics like LSD, magic mushrooms, MDMA and DMT from ayahuasca can help with addiction, depression, phobias, schizophrenia, anxiety and even prisoner recidivism rates. New research on substances like tryptamines, DMT and magic mushrooms; amphetamines, including MDMA; and…
By John Vibes A new trial in the UK, led by a team of researchers at the Imperial College of London, is seeking to determine whether MDMA can help alcoholics overcome their addiction. MDMA is the active ingredient in the club drug known as ecstasy…
By Carey Wedler The case for employing 3,4-methylenedioxymethamphetamine, or MDMA, to treat post-traumatic stress disorder (PTSD) grew stronger this week. A study published in the Lancet Journal of Psychiatry documented promising results when used in conjunction with psychotherapy, adding to previous similar findings. A small study of 26 veterans…
